Krause GC, Lima KG, Dias HB, da Silva EFG, Haute GV, Basso BS, et al
Second , both medications can influence metabolic parameterstirzepatide through direct glucose regulation and weight loss, sermorelin through growth hormone-mediated effects on insulin sensitivity and body composition
Randomized controlled trials specifically powered to assess depressive symptoms with GLP1 therapy are scarce
*Correspondence: Jens Juul Holst [email protected] This article was submitted to Molecular and Structural Endocrinology, a section of the journal Frontiers in Endocrinology Disclaimer All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers
Victoza is FDA-approved to help control blood sugar in type 2 diabetes and can also support weight loss off-label